martingallagher

All posts by martingallagher

November 4th, 2009

Darbepoetin—Trick or Treat? Part I

and

(SEE PART II OF SERIES) When the FDA approved the use of recombinant erythropoietin for patients with renal disease in 1989 it was based upon the ability of this agent to reduce the need for blood transfusion, increase patient’s exercise tolerance and improve quality of life. At the time, the perceived risk of blood transfusion […]